Abstract:The human telomeric G-quadruplex (G4) is an attractive target for developing anticancer drugs. Natural products protoberberine alkaloids are known to bind human telomeric G4 and inhibit telomerase. Among several structurally similar protoberberine alkaloids, epiberberine (EPI) shows the greatest specificity in recognizing the human telomeric G4 over duplex DNA and other G4s. Recently, NMR study revealed that EPI recognizes specifically the hybrid-2 form human telomeric G4 by inducing large rearrangements in the 5'-flanking segment and loop regions to form a highly extensive four-layered binding pocket. Using the NMR structure of the EPI-human telomeric G4 complex, here we perform molecular dynamics free energy calculations to elucidate the ligand selectivity in the recognition of protoberberines by the human telomeric G4. The MM-PB(GB)SA (molecular mechanics-Poisson Boltzmann/Generalized Born) Surface Area) binding free energies calculated using the Amber force fields bsc0 and OL15 correlate well with the NMR titration and binding affinity measurements, with both calculations correctly identifying the EPI as the strongest binder to the hybrid-2 telomeric G4 wtTel26. The results demonstrated that accounting for the conformational flexibility of the DNA-ligand complexes is crucially important for explaining the ligand selectivity of the human telomeric G4. While the MD-simulated (molecular dynamics) structures of the G-quadruplex-alkaloid complexes help rationalize why the EPI-G4 interactions are optimal compared with the other protoberberines, structural deviations from the NMR structure near the binding site are observed in the MD simulations. We have also performed binding free energy calculation using the more rigorous double decoupling method (DDM); however, the results correlate less well with the experimental trend, likely due to the difficulty of adequately sampling the very large conformational reorganization in the G4 induced by the protoberberine binding.

NMR Studies on the Interaction between Oncogene RET G‐Quadruplex and Berberine †

Colchicine Selective Interaction with Oncogene RET G-quadruplex Revealed by NMR.

Ligand Selectivity in the Recognition of Protoberberine Alkaloids by Hybrid-2 Human Telomeric G-Quadruplex: Binding Free Energy Calculation, Fluorescence Binding, and NMR Experiments

Binding of berberine derivates to G-quadruplex: insight from a computational study

Human telomere double G-quadruplex recognition by berberine-bisquinolinium imaging conjugates in vitro and in cells

Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine

Study of alkaloid berberine and its interaction with the human telomeric i-motif DNA structure

Supramolecular complex binding to G-quadruplex DNA: Berberine encapsulated by a planar side arm–tethered β-cyclodextrin

A novel platinum(II) complex with berberine derivative as potential antitumor agent targeting G-quadruplex DNA

A Comparative Study on the DNA Interactions and Biological Activities of Benzophenanthridine and Protoberberine Alkaloids

Evaluate Binding Properties of Synthetic Berbamine Derivatives with the PDGFR-β G-quadruplex by ESI-MS

Comprehensive Study in the Inhibitory Effect of Berberine on Gene Transcription, Including TATA Box

Exploring the Parallel G-Quadruplex Nucleic Acid World: A Spectroscopic and Computational Investigation on the Binding of the c-myc Oncogene NHE III1 Region by the Phytochemical Polydatin

DNA G-quadruplexes as Targets for Natural Product Drug Discovery

Selective stabilization of multiple promoter G-quadruplex DNA by using 2-phenyl-1H-imidazole-based tanshinone IIA derivatives and their potential suppressing function in the metastatic breast cancer

Electrospray Ionization Mass Spectrometry Probing of Binding Affinity of Berbamine, a Flexible Cyclic Alkaloid from Traditional Chinese Medicine, with G-quadruplex DNA.

Effects of Berbamine on Growth of Leukemia Cell Line NB4 and Its Mechanism

Structure–Activity Relationship Study Enables the Discovery of a Novel Berberine Analogue As the RXRα Activator to Inhibit Colon Cancer

Rational design of small-molecules to recognize G-quadruplexes of c-MYC promoter and telomere and the evaluation of their in vivo antitumor activity against breast cancer

Spectroscopy Probing of the Formation, Recognition, and Conversion of A G-Quadruplex in the Promoter Region of the Bcl-2 Oncogene

Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations